These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Alterations of the neutrophil-lymphocyte ratio during the period of stable and acute exacerbation of chronic obstructive pulmonary disease patients. Taylan M, Demir M, Kaya H, Selimoglu Sen H, Abakay O, Carkanat Aİ, Abakay A, Tanrikulu AC, Sezgi C. Clin Respir J; 2017 May; 11(3):311-317. PubMed ID: 26096858 [Abstract] [Full Text] [Related]
5. Neutrophil to lymphocyte ratio is a better indicator of COPD exacerbation severity in neutrophilic endotypes than eosinophilic endotypes. Aksoy E, Karakurt Z, Gungor S, Ocakli B, Ozmen İ, Yildirim E, Tuncay E, Agca MC, Ciftaslan Goksenoglu N, Adigüzel N. Int J Chron Obstruct Pulmon Dis; 2018 May; 13():2721-2730. PubMed ID: 30233162 [Abstract] [Full Text] [Related]
8. Evaluation of the relationship of neutrophil-to lymphocyte ratio and platelet-to-lymphocyte ratio with in-hospital mortality in patients with acute exacerbation of chronic obstructive pulmonary disease. Emami Ardestani M, Alavi-Naeini N. Clin Respir J; 2021 Apr; 15(4):382-388. PubMed ID: 33210811 [Abstract] [Full Text] [Related]
9. Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio are Predictors of Heart Failure. Durmus E, Kivrak T, Gerin F, Sunbul M, Sari I, Erdogan O. Arq Bras Cardiol; 2015 Dec; 105(6):606-13. PubMed ID: 26536980 [Abstract] [Full Text] [Related]
11. The neutrophil/lymphocyte ratio is a better addition to C-reactive protein than CD64 index as a marker for infection in COPD. Farah R, Ibrahim R, Nassar M, Najib D, Zivony Y, Eshel E. Panminerva Med; 2017 Sep; 59(3):203-209. PubMed ID: 28185443 [Abstract] [Full Text] [Related]
13. Usefulness of neutrophil to lymphocyte ratio in patients with chronic obstructive pulmonary disease: a prospective observational study. Lee SJ, Lee HR, Lee TW, Ju S, Lim S, Go SI, You JW, Cho YJ, Lee GW, Jeong YY, Kim HC, Lee JD. Korean J Intern Med; 2016 Sep; 31(5):891-8. PubMed ID: 27017385 [Abstract] [Full Text] [Related]
14. The utility of inflammatory markers to predict readmissions and mortality in COPD cases with or without eosinophilia. Duman D, Aksoy E, Agca MC, Kocak ND, Ozmen I, Akturk UA, Gungor S, Tepetam FM, Eroglu SA, Oztas S, Karakurt Z. Int J Chron Obstruct Pulmon Dis; 2015 Sep; 10():2469-78. PubMed ID: 26648709 [Abstract] [Full Text] [Related]
15. Eosinophilic and non-eosinophilic COPD patients with chronic respiratory failure: neutrophil-to-lymphocyte ratio as an exacerbation marker. Acartürk Tunçay E, Karakurt Z, Aksoy E, Saltürk C, Gungor S, Ciftaslan N, Irmak İ, Yavuz D, Ocakli B, Adıgüzel N. Int J Chron Obstruct Pulmon Dis; 2017 Sep; 12():3361-3370. PubMed ID: 29200843 [Abstract] [Full Text] [Related]
18. Defining the role of neutrophil-to-lymphocyte ratio in COPD: a systematic literature review. Pascual-González Y, López-Sánchez M, Dorca J, Santos S. Int J Chron Obstruct Pulmon Dis; 2018 Sep; 13():3651-3662. PubMed ID: 30464448 [Abstract] [Full Text] [Related]
19. Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio and Complete Blood Count Components in the First Trimester Do Not Predict HELLP Syndrome. Sisti G, Faraci A, Silva J, Upadhyay R. Medicina (Kaunas); 2019 May 28; 55(6):. PubMed ID: 31141974 [Abstract] [Full Text] [Related]